Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 23, 2013
Dr. Janet Woodcock, Director of the Center for Drug Evaluation and Research with the Food and Drug Administration, tells the committee that FDA could have been more aggressive in oversight of compounding pharmacies. "We investigated outbreaks, we investigated reports, and we did respond reactively to problems but we did not proactively do everything we could."